Adaptation of the medical-nutrition therapy for patients with intestinal failure in a developing country: A modified Delphi survey

• Published in: Clinical nutrition ESPEN 2020-12, Vol.40, p.187-192
• Main Authors: Rosas-Flota, Ximena, Castillo-Martínez, Lilia, Reyes-Ramírez, Ana L., Martínez-Soto Holguín, Martha C., Serralde-Zúñiga, Aurora E.
• Format: Article
• Language: English
• Subjects: Consensus; Delphi technique; Guidelines; Intestinal failure; Medical-nutrition therapy
• ISSN: 2405-4577; 2405-4577
• DOI: 10.1016/j.clnesp.2020.09.024

Intestinal Failure (IF) is a complex disease with huge impacts on our society due to complications. Therefore, in a developing country like Mexico without specialized IF clinics, health care professionals must provide evidence-based interventions for the IF patient. This study aims to achieve consensus on how to adapt the existing guidelines for IF to the local practices considering the available resources and local practices. A three-round modified Delphi process was used to build consensus on the most important interventions for our IF patients. For each round, data was collected and consensus was defined as ≥80% of agreement for each item. Descriptive statistics were used to determine whether a consensus was achieved. Ten content experts completed the three-round modified Delphi survey. Consensus was achieved for 98% of the items related to the hospitalized patient, ambulatory care management, and drug therapy. Some of these items are not included in the ESPEN guidelines for IF, but we considered that they are relevant in our clinical practice, like the calculation of fluids for patients with very low body weight, screening for refeeding syndrome and the use of some conventional drugs to promote intestinal rehabilitation. Using a three-round modified Delphi process, consensus was achieved for nearly all items. This represents a starting point for the improvement of our local practices towards this complex disease, leading to better outcomes and the implementation of evidence-based protocolized interventions which can have an important impact due to the lack of access to some of the most novel pharmacological therapies like the glucagon-like-peptide (GLP-2) analog.